The ACCENT trial (Achieving Cannabis Cessation: Evaluating N-Acetylcysteine Remedy), which commenced enrollment in 2014 and it is now in Period three under the purview of UCLA, which examined the use of N-Acetylcysteine as a possible tool for cannabis cessation in adult members. Its materials is presently going through review and https://robertk107zac1.verybigblog.com/profile